Munich – Approximately 9% of patients with early-stage breast cancer who could forgo sentinel lymph node dissection (SLND) based on certain criteria nevertheless have lymph node metastases. The error rate is similarly high for women who would be suitable candidates for partial breast irradiation. This is the finding of a real-world study that...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Munich – Approximately 9% of patients with early-stage breast cancer who could forgo sentinel lymph node dissection (SLND) based on certain criteria nevertheless have lymph node metastases. The error rate is similarly high for women who would be suitable candidates for partial breast irradiation. This is the finding of a real-world study that...